Donald E Mager

14PUBLICATIONS
58CO-AUTHORS
Molecular targetsPharmacogenomicsHaematological tumoursClinical pharmacology and therapeuticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 29, 2026
Insights and perspectives into the etiology of TKI-induced cardiotoxicity.

|May 05, 2026
PK-PD Modeling Suggests Tumor Heterogeneity Limits Preclinical to Clinical Translation of Enzalutamide in Prostate Cancer.

|Apr 14, 2026
Hybrid Systems Modeling of Donor T-Cell Responses and Graft-Versus-Host-Disease After Posttransplantation Cyclophosphamide Administration.

Hsuan-Hao Fan, Jeannine S McCune, Christopher G Kanakry

|Mar 19, 2026
Binding Kinetics Can Explain Linear and Nonlinear Pharmacokinetics of Dipeptidyl Peptidase-IV Inhibitors Within a Single Target-Mediated Framework.

Adam Elalem, Mfonabasi E Ette, Donald E Mager

|Nov 25, 2025
B Cell Differentiation Model for Identifying Predictors of Responses to Rituximab-Mediated B Cell Depletion in Rheumatic Diseases.

Tomohisa Nakada, Donald E Mager

|Nov 11, 2025
Translatability of Animal Models for Alzheimer's Disease Using a Machine Learning Based Workflow.

Alex Foster-Powell, Guy Meno-Tetang, Amin Rostami-Hodjegan

Pageof 3

Frequent Collaborators

2 joint publications

Jeannine S McCune

2 joint publications

Guy Meno-Tetang

2 joint publications

Alex Foster-Powell

2 joint publications

Christopher G Kanakry